Hjem › Endometriekreft › Nevada
Kliniske studier for Endometriekreft i Nevada
8 studier for Endometriekreft søker deltakere på steder i Nevada.
Byer i Nevada
Offisiell studietekst (engelsk)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- OptumCare Cancer Care at Charleston, Las Vegas
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
- Summerlin Hospital Medical Center, Las Vegas
- og 2 flere
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05564377Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Women's Cancer Center of Nevada, Las Vegas
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 2. okt. 2026 · NCT07198074Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Women's Cancer Center of Nevada, Las Vegas
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 28. sep. 2026 · NCT05112601Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Womens Cancer Center of Nevada, Las Vegas
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 24. sep. 2026 · NCT05640999A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- The Center of Hope Reno, Reno
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 17. sep. 2026 · NCT06340568A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Comprehensive Cancer Centers of Nevada, Las Vegas
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT05377996Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Women's Cancer Center of Nevada, Las Vegas
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. nov. 2025 · NCT05997017Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Women's Cancer Center of Nevada, Las Vegas
RekruttererFase 2/3
Alder 18 og eldre · Kvinner · Oppdatert 2. mai 2024 · NCT05797831Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.